Intravascular Ultrasound (IVUS) Global Strategic Business Report 2025-2030 - Cumulative Revenues to Cross $1.1 Billion by 2030 Driven by Patients' Growing Preference for MIS [Yahoo! Financ...
Johnson & Johnson (JNJ)
Last johnson & johnson earnings: 4/14 06:31 am
Check Earnings Report
US:NYSE Investor Relations:
jnj.com
Company Research
Source: Yahoo! Finance
8.4%. The IVUS Consoles segment is also set to grow at 6.7% CAGR over the analysis period. Dublin, April 24, 2025 (GLOBE NEWSWIRE) -- The "Intravascular Ultrasound (IVUS) - Global Strategic Business Report" has been added to ResearchAndMarkets.com's offering. The global market for Intravascular Ultrasound (IVUS) was valued at US$731.8 Million in 2024 and is projected to reach US$1.1 Billion by 2030, growing at a CAGR of 7.7% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Intravascular Ultrasound (IVUS) market. The growth in the IVUS market is driven by several factors, including technological advancements, increased prevalence of cardiovascular diseases, and rising demand for minimally invasive procedures. Technological innovations in IVUS systems, such as improved image resoluti
Show less
Read more
Impact Snapshot
Event Time:
JNJ
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
JNJ alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
JNJ alerts
High impacting Johnson & Johnson news events
Weekly update
A roundup of the hottest topics
JNJ
News
- Johnson & Johnson completes acquisition of Halda Therapeutics and its novel platform to revolutionize cancer treatment and enable next-generation oral therapies [Yahoo! Finance]Yahoo! Finance
- Johnson & Johnson completes acquisition of Halda Therapeutics and its novel platform to revolutionize cancer treatment and enable next-generation oral therapiesBusiness Wire
- Notable healthcare headlines for the week: J&J, Pfizer, and Novo Nordisk in focus [Seeking Alpha]Seeking Alpha
- JonesTrading Highlights Differentiated Pipeline at Atai Beckley N.V. (ATAI) [Yahoo! Finance]Yahoo! Finance
- Johnson & Johnson Terminates Trial of Atopic Dermatitis Drug Candidate [Yahoo! Finance]Yahoo! Finance
JNJ
Earnings
- 10/14/25 - Beat
JNJ
Sec Filings
- 12/11/25 - Form 4
- 12/11/25 - Form 4
- 12/11/25 - Form 4
- JNJ's page on the SEC website